Author

Nada S. Aboelella

University of ChicagoORCID 0000-0002-9009-9897Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Caitlin Brandle· 1 shared Catherine C. HedrickiD· 1 shared David W. WolffiD· 1 shared Dongwen LviD· 1 shared Duy-Thuc NguyeniD· 1 shared Erting TangiD· 1 shared Gang ZhouiD· 1 shared Gary Anthony PiazzaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Caitlin Brandle

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer Immunology ResearchPeer-reviewedMay 8, 2026

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy

Erting Tang, Yifei Hu, Guoshuai Cao…·Jun Huang

This study shows that low-strength type I interferon signaling enhances CAR T-cell efficacy against B-cell lymphoma and leukemia without causing in vivo toxicity.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 8, 2026

Indomethacin exerts both cyclooxygenase inhibition-dependent and independent mechanisms to enhance chemo-immunotherapy in mice

Ogacheko D. Okoko, Nada S. Aboelella, Yan Ye…·Gang Zhou

This study shows indomethacin enhances chemo-immunotherapy in mice through both COX-dependent and independent mechanisms, including RAS inhibition.

1 citation

mousescRNA-seq

𝕏 PostBluesky